July 24, 2014 5:44 PM ET

Capital Markets

Company Overview of Paragon Pharmaceuticals, LLC

Company Overview

Paragon Pharmaceuticals is a principal investment firm specializing in acquisition of pharmaceutical companies. The firm typically invests in therapeutics, rare diseases, gastrointestinal therapy, oncology, pain management, central nervous system disorders, and drug development. It seeks to invest along with other investors. Paragon Pharmaceuticals was founded in December 2009 and is based in Northbrook, Illinois.

1033 Skokie Boulevard

Northbrook, IL 60062

United States

Founded in 2009





Key Executives for Paragon Pharmaceuticals, LLC

Age: 46
Executive Vice President of Global Development
Executive Vice President of Legal Affairs and Mergers & Acquisitions and General Counsel
Principal and Senior Advisor
Age: 58
Mergers and Acquisitions Advisor
Age: 56
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Winchester Financial Advisors, LLC United States
Tucker Cleary Capital Markets United States
Questcom Media Brokerage, Inc. United States
Austin Stock Research, L.P. United States
Whitnell & Co. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Paragon Pharmaceuticals, LLC, please visit www.paragonpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.